Yau‐Lin Tseng

3.3k total citations
123 papers, 1.9k citations indexed

About

Yau‐Lin Tseng is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yau‐Lin Tseng has authored 123 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Surgery, 59 papers in Pulmonary and Respiratory Medicine and 21 papers in Oncology. Recurrent topics in Yau‐Lin Tseng's work include Lung Cancer Diagnosis and Treatment (24 papers), Tracheal and airway disorders (16 papers) and Esophageal and GI Pathology (16 papers). Yau‐Lin Tseng is often cited by papers focused on Lung Cancer Diagnosis and Treatment (24 papers), Tracheal and airway disorders (16 papers) and Esophageal and GI Pathology (16 papers). Yau‐Lin Tseng collaborates with scholars based in Taiwan, United States and United Kingdom. Yau‐Lin Tseng's co-authors include Wu‐Wei Lai, Yi‐Ting Yen, Frank J. M. F. Dor, David K. C. Cooper, David H. Sachs, Kazuhiko Yamada, Henk‐Jan Schuurman, Kenji Kuwaki, Ming-Ho Wu and Stuart L. Houser and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Yau‐Lin Tseng

117 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yau‐Lin Tseng Taiwan 22 968 495 457 378 288 123 1.9k
George H. Yoo United States 29 804 0.8× 416 0.8× 181 0.4× 553 1.5× 870 3.0× 81 2.3k
Agnese Proietti Italy 22 409 0.4× 307 0.6× 159 0.3× 429 1.1× 420 1.5× 83 1.8k
Lydia Deschamps France 22 408 0.4× 250 0.5× 207 0.5× 190 0.5× 446 1.5× 81 1.6k
Sanjay Logani United States 24 503 0.5× 231 0.5× 168 0.4× 526 1.4× 352 1.2× 37 1.8k
Hiroyuki Hayashi Japan 23 431 0.4× 541 1.1× 97 0.2× 379 1.0× 477 1.7× 111 1.6k
Kenneth Tou En Chang Singapore 22 478 0.5× 591 1.2× 68 0.1× 340 0.9× 341 1.2× 144 1.8k
Robert L. Saylors United States 23 287 0.3× 292 0.6× 257 0.6× 836 2.2× 550 1.9× 36 1.9k
Yoshihisa Kadota Japan 22 402 0.4× 475 1.0× 143 0.3× 147 0.4× 227 0.8× 67 1.7k
Martha Quezado United States 23 412 0.4× 300 0.6× 90 0.2× 341 0.9× 210 0.7× 61 1.7k
Bhuvaneswari Krishnan United States 20 381 0.4× 665 1.3× 180 0.4× 800 2.1× 391 1.4× 50 1.8k

Countries citing papers authored by Yau‐Lin Tseng

Since Specialization
Citations

This map shows the geographic impact of Yau‐Lin Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yau‐Lin Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yau‐Lin Tseng more than expected).

Fields of papers citing papers by Yau‐Lin Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yau‐Lin Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yau‐Lin Tseng. The network helps show where Yau‐Lin Tseng may publish in the future.

Co-authorship network of co-authors of Yau‐Lin Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Yau‐Lin Tseng. A scholar is included among the top collaborators of Yau‐Lin Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yau‐Lin Tseng. Yau‐Lin Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chung-Teng, Tangchun Wu, Yu-Chih Wu, et al.. (2025). OCT4-mediated upregulation of DUSP6 promotes metastasis in non-small-cell lung cancer. Journal of Cancer. 16(14). 4172–4186.
2.
Wang, Chung-Teng, Jia‐Ming Chang, Yi‐Ting Yen, et al.. (2025). OCT4 promotes lung cancer progression through upregulation of VEGF-correlated chemokine-1. International Journal of Medical Sciences. 22(3). 680–695. 6 indexed citations
3.
Chao, Yin‐Kai, Jui‐Ying Lee, Wen‐Chien Huang, et al.. (2024). Robot-assisted minimally invasive oesophagectomy versus thoracoscopic approach: multi-institutional study on short-term outcomes. BJS Open. 8(4). 1 indexed citations
4.
Young, Ming-Jer, Shao‐An Wang, Chia-Yu Liu, et al.. (2024). USP24-i-101 targeting of USP24 activates autophagy to inhibit drug resistance acquired during cancer therapy. Cell Death and Differentiation. 31(5). 574–591. 14 indexed citations
6.
Chang, Chao‐Chun, Yi‐Ting Yen, Yau‐Lin Tseng, et al.. (2023). Low neutrophil-to-lymphocyte ratio predicts overall survival benefit in advanced NSCLC patients with low PD-L1 expression and receiving chemoimmunotherapy. Frontiers in Oncology. 13. 1238876–1238876. 2 indexed citations
7.
Lin, Chia-Ying, Shu‐Mei Guo, Jenn-Jier James Lien, et al.. (2023). Combined model integrating deep learning, radiomics, and clinical data to classify lung nodules at chest CT. La radiologia medica. 129(1). 56–69. 30 indexed citations
8.
Young, Ming-Jer, Chia-Yu Liu, Chia-Chi Lee, et al.. (2022). Estradiol-mediated inhibition of DNMT1 decreases p53 expression to induce M2-macrophage polarization in lung cancer progression. Oncogenesis. 11(1). 25–25. 25 indexed citations
10.
Su, Po‐Lan, Szu‐Chun Yang, Chao‐Chun Chang, et al.. (2021). EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis. Journal of the Formosan Medical Association. 120(9). 1729–1739. 10 indexed citations
11.
Yang, Szu‐Chun, Chao‐Chun Chang, Chia‐Ying Lin, et al.. (2021). Improved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors. Thoracic Cancer. 13(2). 182–189. 3 indexed citations
12.
Chen, Ying‐Yuan, Yi‐Ting Yen, Wu‐Wei Lai, et al.. (2021). Outcomes of salvage lung resections in advanced EGFR‐mutant lung adenocarcinomas under EGFR TKIs. Thoracic Cancer. 12(20). 2655–2665. 12 indexed citations
13.
Su, Po‐Lan, Szu‐Chun Yang, Yilin Chen, et al.. (2019). Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment. Cancer Medicine. 8(13). 5939–5947. 11 indexed citations
14.
Yen, Yi‐Ting, Hung-Chi Cheng, Yi‐Chieh Chen, et al.. (2016). Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis. Clinical Cancer Research. 23(9). 2335–2345. 44 indexed citations
15.
Tseng, Yau‐Lin, Jia‐Ming Chang, Yi‐Sheng Liu, et al.. (2016). The Role of Video-Assisted Thoracoscopic Therapeutic Resection for Medically Failed Pulmonary Tuberculosis. Medicine. 95(18). e3511–e3511. 9 indexed citations
16.
Tu, Ching‐Fu, Hao‐Chih Tai, David Wang, et al.. (2007). Effects of expression level of human DAF alone and with human HO-1 in transgenic pig kidney ex-vivo perfused with freshly collected human blood. Xenotransplantation. 14(5). 382–383. 2 indexed citations
17.
Tseng, Yau‐Lin, et al.. (2007). Ileocolon Graft Pedicled on Ileocolic Artery: An Alternative Esophageal Substitute for Corrosive Injury. The Annals of Thoracic Surgery. 84(1). 295–296. 1 indexed citations
18.
Dor, Frank J. M. F., Yau‐Lin Tseng, Jane Cheng, et al.. (2004). α1,3-Galactosyltransferase Gene-Knockout Miniature Swine Produce Natural Cytotoxic Anti-Gal Antibodies. Transplantation. 78(1). 15–20. 68 indexed citations
19.
Chen, Fen-Fen, et al.. (2001). Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer. The Annals of Thoracic Surgery. 72(6). 1868–1876. 34 indexed citations
20.
Lai, Wu‐Wei, et al.. (1995). Bronchial Rupture Caused by Blunt Chest Injury. Annals of Emergency Medicine. 25(3). 412–415. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026